Search by Drug Name or NDC

    NDC 65649-0231-41 Azasan 75 mg/1 Details

    Azasan 75 mg/1

    Azasan is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Salix Pharmaceuticals. The primary component is AZATHIOPRINE.

    Product Information

    NDC 65649-0231
    Product ID 65649-231_0cceeb5c-3f54-cca0-e063-6394a90a3b95
    Associated GPIs 99406010000315
    GCN Sequence Number 051793
    GCN Sequence Number Description azathioprine TABLET 75 MG ORAL
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 19170
    HICL Sequence Number 004523
    HICL Sequence Number Description AZATHIOPRINE
    Brand/Generic Brand
    Proprietary Name Azasan
    Proprietary Name Suffix n/a
    Non-Proprietary Name Azathioprine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 75
    Active Ingredient Units mg/1
    Substance Name AZATHIOPRINE
    Labeler Name Salix Pharmaceuticals
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075252
    Listing Certified Through 2024-12-31

    Package

    NDC 65649-0231-41 (65649023141)

    NDC Package Code 65649-231-41
    Billing NDC 65649023141
    Package 100 TABLET in 1 BOTTLE (65649-231-41)
    Marketing Start Date 2003-04-01
    NDC Exclude Flag N
    Pricing Information N/A